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Deposition of amyloid material in various tissues is an occasional sequelae of
various autoimmune disorders, chronic infections, and myeloma in man (1).
Histologically similar lesions can be induced in experimental animals by re-
peated injections of casein (2) . As the amyloid deposits in both these instances
comprise material derived from gamma globulin molecules (3) it has been
suggested that both clinical (1) and experimental amyloidosis (4) invoke hyper-
sensitivity or autoimmune reactions . However, amyloidosis can be induced in
neonatally thymectomized mice (5) and animals made immunologically tolerant
to casein (5). Therefore, the immunological background to at least casein-
induced experimental amyloidosis remains obscure . In this communication we
have studied the in vitro effects of casein on spleen cells from amyloid-suscepti-
ble and amyloid-resistant mice with reference to polyclonal antibody production
and DNA synthesis .
In Vitro Procedures
Materials and Methods
Animals .
￿
Inbred mice of strains A/Jax, CBA/Jax, and CBA/C57BL from the colonies at the
Department ofBacteriology, Life Sciences,U. C. L. A., Los Angeles, Calif ., and the Department of
Immunobiology, Wallenberglaboratory, Stockholm, Sweden were used . They were kept under
similar conditions and were originally purchased from The Jackson Laboratory, Bar Harbor,
Maine . The animals were 3- to 4-mo old when used and they were all females .
Mitogens .
￿
Lipopolysaccharide (LPS)' from Escherichia coli 055:B5 was used as a B-cell mito-
gen and polyclonal activator (PBA) (6) . It was produced and handled as described previously (6) .
Phytohemagglutinin (PHA-P, BurroughsWellcome& Co ., Inc., Tuckahoe, N. Y.) was used as aT-
cell mitogen . Casein in the form of sodium caseinate was purchased from National Biochemical
Co ., Chicago, Ill., and dissolved in buffered isotonic saline . It was ultrafiltrated before used in
tissue culture experiments .
TISSUE CULTURE TECHNIQUES .
￿
Mouse spleen cells were prepared and kept in culture essen-
tially as described by Mishell and Dutton (7) although at a microscale . Thus, 0.2 ml of the cell
suspension at aconcentration of 10'/ml was cultivated in a well on a sealed microplate (Microtest ;
* These studies received support from the Swedish Medical Research Council (grant B76-16X-
03780-05).
Abbreviations used in this paper: LPS, lipopolysaccharide ; PBA, polyclonal activator ; PHA,
phytohemagglutinin ; PPD, purified protein derivative of tuberculin .
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DNA-Synthetic Response ofMouse (CBA x C57BL) Spleen Cells Exposed for
2 days to Various Doses ofPHA, LPS, and Casein
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Falcon Plastics, Div. of BioQuest, Oxnard, Calif.). All cultures were done under serum-free
conditions.
THE AGAR PLAQUE TECHNIQUE.
￿
The agar plaque techniqueofJerneet al. (8)with modifications
(9) was used for detection of single antibody-forming cells. Target cells were NNP-haptenated
sheep redblood cells (type II) according to a chemical coupling procedureof Pasanen andMakela
(10) . Cellsfrom threecultures were pooled. Mean values from two slides ofthis pool are indicated.
DNA sYNTHEsis.
￿
DNA synthesis of cultivated cells was determined by exposing the cells to 2
p.Ci [3H]thymidine (The Radiochemical Centre,Amersham, England) for 18 h under microculture
conditions as above. After this the cellswere collectedon glassfilters, washed several timeswith
water, and the retained radioactivity determined in a liquid scintillation counter (Tri-Carb,
Packard Instrument Co., Inc., Downers Grove, Ill.).
In Vivo Procedures. The capacity of sodium caseinate to induce peritoneal exudate was
checkedby injecting 2 ml of a 10%solution of sodium caseinateintraperitoneally. 3days laterthe
peritoneal cavity was rinsed with 5 ml of saline andthe recovered cellscountedin phase-contrast
microscopy. Thymus cell-deprived mice were obtained by thymectomizing adult animals which
were 2 wk later lethally irradiated andrepopulated with 50 x 108syngeneicfetal liver cells. Their
spleens were used 3 wk later.
Results
TheEffect ofCasein on DNA Synthesis andPolyclonal Antibody Synthesis in
Mouse Spleen Cells. Various concentrations ofsodium caseinate were added to
mouse (CBA/C57BL) spleen cells, and the DNA synthesis (Table I) and poly-
clonal antibody synthesis (Table II) as revealed by the number formation of
direct anti-NNP-producing cells (NNP-PFC) was determined after 2 days. The
values were compared with those obtained with cells exposed to LPS and PHA,
respectively.
It can be seen that casein was a mitogen (Table I), although weaker than LPS
and PHA. Sodium caseinate induced strong polyclonal antibody formations in
mouse spleen cells (Table II) as did LPS, but notPHA (Table II). Casein induced
a maximal response at a slightly lower concentration than LPS.
The kinetics of induction of polyclonal antibody formation with LPS and
sodium caseinate were similar, although peak responses for casein appeared to
be somewhat delayed (Table III). The responder cell to sodium caseinate was
present in spleen cells from thymectomized lethally irradiated fetal liver recon-
stituted mice, because such cells responded both with increased DNA and
Dose/ml
PHA
Substance
LPS
added
Sodium caseinate
mean of three cultures ± 1 SE
- 3.460 ± 180 3.460 ± 180 3.460 ± 180
0.1 18.770 ± 1.320 3.250 ± 110 3.810 ± 340
1 59.720 -t 3.150 6.040 ± 1.940 9.130 ± 640
10 44.160 ± 1.240 19.160 ± 1.950 15.460 ± 990
100 9.330 ± 1.770 38.800 ± 2.510 14.600 ± 1.570
500 1.460 ± 1.550 33.590 ± 1.790 9.990 ± 1.3201566
TABLE II
Number ofAnti-NNP Plaque-Forming Cells/108 Recovered Cells
in CBA x C57BL Mouse Spleen Cells Exposed to Various Doses
ofPHA, LPS, and Casein, Respectively, for 2 days
TABLE III
Number ofAnti-NNP Plaque-Forming Cells/108 Recovered Cells
in Spleen Cells from CBA x C57BL Mice Exposed to 100 jigLPS
and Casein, Respectively, for Varying Times
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polyclonal antibody synthesis to casein, whereas they were absolutely nonre-
sponsive to the mitogenic effect ofPHA (Table IV).
Genetic Variation in Susceptibility ofMouse Spleen Cells to Sodium Casein-
ate. Since casein-induced experimental amyloidosis can be readily induced in
CBA/J mice, but not in A/J mice (2), spleen cells from these two strains ofmice
were exposed to casein (Table V) and their polyclonal antibody synthesis was
determined (Table V). It canbe seen that sodium caseinatewas amuch stronger
inducer of polyclonal antibody synthesis in spleen cells from CBA/J mice than
fromA/J mice, although the background response in nonstimulated CBA spleen
cells was also higher.
The tissue-irritating capacityofsodium caseinatewas compared in CBA/J and
A/J mice. Tothis end, the animalswereinjected intraperitoneally with 2 ml ofa
10% solution of sodium caseinate and the number of cells in the peritoneal
exudate determined 3 days later (Table VI). The tissue-irritant capacity of
sodium caseinate was similar in these strains of mice.
Discussion
Much evidence now suggests (1) that amyloidosis in man is immunological in
nature. This is mainly so because of the prominence of immunoglobulin mate-
rial in many ofthe amyloid deposits.
Dose/ml
lug
PHA
Substance added
LPS Casein
- 16 16 16
0.1 12 20 18
1 28 34 38
10 8 182 494
100 0 346 896
500 0 702 540
Days in
culture LPS
Substance added
Casein None
1 42 38 14
2 490 522 28
3 525 970 32
4 180 806 10Material
added
Material
injected
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TABLE IV
DNA-Synthetic response and Anti-NNP PFC Response of Spleen Cells from
Normal (N) and Thymectomized Lethally Irradiated Fetal Liver
Reconstituted (T x FL) Mice (CBA x C57BL) Exposed to PHA (1 pg) and
Casein (100 pg) for 2 days
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TABLE V
Polyclonal Antibody Synthesis (anti-NNP-PFC) of Spleen cells from Amyloid-
Susceptible (CBAIJ)andAmyloid-Resistant (AIJ) Mice Exposed to 100 pg ofCasein for2
(exp . I) or 3 (exps. II and 111) days
NNP-PFC/108 recovered cells in mouse strain
A/J
￿
CBA/J
Exp. I
￿
II
￿
III
￿
Exp. I
￿
II
Casein 80 106 158 655 1,208 906
None
￿
12 8 8
￿
36 54 40
TABLE VI
Number ofCells x 108 in the Peritoneal Cavity ofAIJ and CBA/J
Mice 3 days after an i.p . Injection of2 ml 10% Sodium Caseinate
or Saline
A/J
￿
CBA/J
mean ± SE ofsix mice
Casein
￿
8.4 ± 1.2
￿
7.6 ± 0.8
Saline
￿
0.80 ± 0.16
￿
0.52 ± 0.08
Experimental amyloidosis in mice andguinea pigs appears to be analogous to
casein-induced amyloidosis (2). It is not known whyrepeated injections ofcasein
into animals result in lesions very similar to those seen in amyloidosis in man.
Although immunological factors have been invoked (4), a direct immunological
effect has been excluded, because both neonatally thymectomized animals (5)
andanimals madetoleranttocasein (5) will developcasein-inducedamyloidosis.
Lately, it has been suggested (11) that casein would affect subpopulation of T
cells, because lymphoid cells of the preamyloid animal displayed an impaired
response to T-cell mitogens. Although not experimentally verified, it was also
suggested (11) that casein would in fact negatively influence a suppressor T-cell
subpopulation (12).
Substance
added
DNA
TxFL
synthesis
N
NNP-PFC
TxF N
None 6.450 ± 920 3.120 ± 470 28 12
PHA 4.920 ± 1.200 87.120 ± 2.770 6 18
Casein 17 .040 ± 620 19.180 ± 1.190 748 4541568
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In this communication we demonstrate that casein has a mitogenic effect on
what appears to be B lymphocytes (Tables I and IV) and that it induces strong
polyclonal antibody synthesis in mouse spleen cells (Tables II and IV). The
selectivity of its triggering capacity in B cells (relatively weak inducerofDNA-
synthesis, but strong inducer of polyclonal antibody formation) makes it most
similar to purified protein derivative of tuberculin (PPD) as a PBA (13) . Our
data explain why neonatally thymectomized animals and animals made immu-
nologically tolerant to casein still develop amyloidosis if regularly injected with
casein, because the PBA properties of casein would be unaffected by both these
regimens .
We also demonstrated that spleen cells from amyloid-susceptible CBA/J mice
responded much stronger with polyclonal antibody production to casein than
cells from the amyloid-resistant A/J mice (Table V), and that a similar differ-
ence could not be observed between these two strains of mice regarding the
tissue irritating and chemoattractant effects of sodium caseinate (Table VI) .
From our data we suggest that a main feature of casein-induced experimental
amyloidosis is the capacity of casein to promote the development of polyclonal
antibody synthesis in B cells and that susceptibility to this activity of casein is
under genetic influence .
Two other agents have also been used as inducers of experimental amyloi-
dosis, i .e ., LPS fromE. coli (14) and Freund's adjuvant (15) . It is not surprising
that both these substances contain material which is strongly mitogenic to
mouse B lymphocytes (13) .
In several instances (1) where amyloidosis is seen in man there is also a
possibility of a sustained exposure to molecules with PBA properties, i.e ., in
chronic gram-negative infections (LPS) and in tuberculosis (PPD) . In other
cases, a malignant monoclonal hypergammaglobulinemia (multiple myeloma)
may result in increased tissue deposition of gamma globulin in the amyloid
form . However, as amyloidosis is also seen in agammaglobulinemic individuals
(1), it cannot be due to a simple hyperproduction ofgamma globulin ofpolyclonal
or monoclonal origin which eventually leads to amyloidosis .
As well as there are genetic differences in the susceptibility to PBA in mice
(Table V and reference 16) there may be similar differences in man. In addition
there may be genetic variations in the catabolism of proteins and in the ability
of the reticuloendothelial system to deposit gamma globulin in the amyloid
form . I also believe that different classes ofgamma globulin may have different
affinities for tissue deposition . Thus, I wish to explore whether there is any
selectivity with regard to class or physical properties of the immunoglobulin
molecules induced to secretion by casein .
Summary
Experimental amyloidosis in mice can be induced by repeated injections of
casein . It has now been demonstrated that casein induces strong polyclonal
antibody synthesis in mouse B spleen lymphocytes . This effect is much more
pronounced in spleen cells from amyloid-susceptible mice (CBA/J)than amyloid-
resistant mice (A/J) . It is suggested that amyloidosis can be due in someinstances to a constant exposure for molecules which induce polyclonal B-cell
activation.
The experimental work was done by Ulla Claeson.
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